Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DVA NYSE:FMS NASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVADaVita$198.39-0.1%$162.93$101.00▼$202.69$12.75B0.841.09 million shs628,732 shsFMSFresenius Medical Care AG & Co. KGaA$21.70-3.6%$22.42$20.02▼$29.71$12.57B0.81855,347 shs390,104 shsPGNYProgyny$24.88+0.8%$19.06$16.10▼$28.75$1.93B0.911.79 million shs1.46 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVADaVita+1.04%+3.35%+32.75%+31.81%+41.15%FMSFresenius Medical Care AG & Co. KGaA+1.42%+4.73%-1.85%-7.76%-24.42%PGNYProgyny-3.71%+7.96%+37.01%+17.68%+16.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVADaVita$198.39-0.1%$162.93$101.00▼$202.69$12.75B0.841.09 million shs628,732 shsFMSFresenius Medical Care AG & Co. KGaA$21.70-3.6%$22.42$20.02▼$29.71$12.57B0.81855,347 shs390,104 shsPGNYProgyny$24.88+0.8%$19.06$16.10▼$28.75$1.93B0.911.79 million shs1.46 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVADaVita+1.04%+3.35%+32.75%+31.81%+41.15%FMSFresenius Medical Care AG & Co. KGaA+1.42%+4.73%-1.85%-7.76%-24.42%PGNYProgyny-3.71%+7.96%+37.01%+17.68%+16.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDVADaVita 2.38Hold$199.170.39% UpsideFMSFresenius Medical Care AG & Co. KGaA 1.56Reduce$28.0029.06% UpsidePGNYProgyny 2.92Moderate Buy$29.5518.75% UpsideCurrent Analyst Ratings BreakdownLatest FMS, DVA, and PGNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026PGNYProgyny Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$19.00 ➝ $30.005/15/2026PGNYProgyny BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$23.00 ➝ $27.005/11/2026DVADaVita TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$144.00 ➝ $201.005/11/2026PGNYProgyny CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/11/2026DVADaVita TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$144.00 ➝ $201.005/11/2026PGNYProgyny Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$28.00 ➝ $30.005/11/2026PGNYProgyny Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$30.00 ➝ $31.005/8/2026DVADaVita Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$158.00 ➝ $205.005/8/2026FMSFresenius Medical Care AG & Co. KGaA Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Moderate Sell5/7/2026FMSFresenius Medical Care AG & Co. KGaA Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)5/7/2026DVADaVita BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$158.00 ➝ $194.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDVADaVita$13.64B0.93$21.68 per share9.15($7.42) per share-26.74FMSFresenius Medical Care AG & Co. KGaA$22.20B0.55$5.37 per share4.04$29.76 per share0.73PGNYProgyny$1.29B1.51$0.74 per share33.54$5.61 per share4.43Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDVADaVita$746.80M$10.7818.4010.800.655.65%-270.37%4.87%8/5/2026 (Estimated)FMSFresenius Medical Care AG & Co. KGaA$1.11B$1.9011.428.934.064.88%8.90%4.05%8/4/2026 (Estimated)PGNYProgyny$58.52M$0.7732.3118.851.315.23%13.34%9.03%8/6/2026 (Estimated)Latest FMS, DVA, and PGNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026PGNYProgyny$0.2560$0.29+$0.0340$0.29$326.47 million$328.50 million5/5/2026Q1 2026DVADaVita$2.33$2.87+$0.54$2.87$3.36 billion$3.42 billion5/5/2026Q1 2026FMSFresenius Medical Care AG & Co. KGaA$0.59$0.53-$0.06$0.25$5.41 billion$5.34 billion3/31/2026Q1 2026FMSFresenius Medical Care AG & Co. KGaAN/A$1.0530N/A$0.25N/A$5.34 billion2/26/2026Q4 2025PGNYProgyny$0.38$0.48+$0.10$0.14$314.26 million$318.40 million2/24/2026Q4 2025 (Media)FMSFresenius Medical Care AG & Co. KGaA$0.67$0.83+$0.16$0.67$4.80 billion$5.95 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDVADaVitaN/AN/AN/AN/AN/AFMSFresenius Medical Care AG & Co. KGaA$0.572.63%+2.66%30.00%N/APGNYProgynyN/AN/AN/AN/AN/ALatest FMS, DVA, and PGNY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026FMSFresenius Medical Care AG & Co. KGaAannual$0.87164.02%5/22/20265/22/20266/8/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDVADaVitaN/A1.421.37FMSFresenius Medical Care AG & Co. KGaA0.401.200.86PGNYProgynyN/A2.132.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDVADaVita90.12%FMSFresenius Medical Care AG & Co. KGaA8.37%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipDVADaVita1.50%FMSFresenius Medical Care AG & Co. KGaAN/APGNYProgyny9.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDVADaVita78,00064.20 million63.24 millionOptionableFMSFresenius Medical Care AG & Co. KGaA1,488558.58 millionN/AOptionablePGNYProgyny31078.33 million70.58 millionOptionableFMS, DVA, and PGNY HeadlinesRecent News About These CompaniesProgyny (NASDAQ:PGNY) CFO Sells $211,012.50 in StockMay 22 at 8:01 AM | insidertrades.comFideuram Intesa Sanpaolo Private Banking S.P.A. Takes Position in Progyny, Inc. $PGNYMay 22 at 3:57 AM | marketbeat.comProgyny Inc (PGNY) Stock Down 3.8% -- Now Undervalued? GF Score: 87/100May 22 at 1:00 AM | gurufocus.comProgyny, Inc. (PGNY) Shareholder/Analyst Call TranscriptMay 21 at 5:01 PM | seekingalpha.comProgyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Moderate Buy" from AnalystsMay 19 at 2:22 AM | americanbankingnews.comProgyny and Standex International have been highlighted as Zacks Bull and Bear of the DayMay 18, 2026 | sharewise.comSBull of the Day: Progyny (PGNY)May 18, 2026 | zacks.comProgyny, Inc. $PGNY Shares Sold by Thrivent Financial for LutheransMay 17, 2026 | marketbeat.comShareholders Will Be Pleased With The Quality of Progyny's (NASDAQ:PGNY) EarningsMay 16, 2026 | finance.yahoo.comProgyny, Inc. $PGNY Shares Bought by First Eagle Investment Management LLCMay 14, 2026 | marketbeat.com151,931 Shares in Progyny, Inc. $PGNY Purchased by Simcoe Capital LLCMay 13, 2026 | marketbeat.comCritical Review: Progyny (NASDAQ:PGNY) & Solventum (NYSE:SOLV)May 13, 2026 | americanbankingnews.comProgyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comProgyny (NASDAQ:PGNY) Given New $31.00 Price Target at Citizens JmpMay 12, 2026 | americanbankingnews.comProgyny (NASDAQ:PGNY) Given New $30.00 Price Target at Truist FinancialMay 12, 2026 | americanbankingnews.com3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNYMay 11, 2026 | zacks.comA Look At Progyny (PGNY) Valuation After Raised Guidance And Share RepurchaseMay 11, 2026 | finance.yahoo.comProgyny (NASDAQ:PGNY) Stock Price Expected to Rise, Truist Financial Analyst SaysMay 11, 2026 | marketbeat.comProgyny, Inc. to Present at BofA Securities 2026 Health Care ConferenceMay 11, 2026 | globenewswire.comCitizens Jmp Forecasts Strong Price Appreciation for Progyny (NASDAQ:PGNY) StockMay 11, 2026 | marketbeat.comVanguard Group Inc. Has $247.39 Million Holdings in Progyny, Inc. $PGNYMay 9, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000By Jeffrey Neal Johnson | May 12, 2026NVIDIA’s China Connection: Investor Risks With Earnings AheadBy Thomas Hughes | May 5, 2026Years in the Making, AMD’s Upside Movement Has Just BegunBy Thomas Hughes | May 6, 2026FMS, DVA, and PGNY Company DescriptionsDaVita NYSE:DVA$198.39 -0.27 (-0.13%) Closing price 03:59 PM EasternExtended Trading$193.50 -4.89 (-2.47%) As of 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Fresenius Medical Care AG & Co. KGaA NYSE:FMS$21.70 -0.81 (-3.58%) Closing price 03:59 PM EasternExtended Trading$21.66 -0.04 (-0.18%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.Progyny NASDAQ:PGNY$24.88 +0.19 (+0.77%) Closing price 04:00 PM EasternExtended Trading$24.19 -0.69 (-2.77%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
